Binder IP definition

Binder IP means the Intellectual Property described in Item (2) of Schedule 2.2(l).
View Source
Binder IP means (a) all Know-How generated by or on behalf of either party after the Effective Date in the course of performing activities under this Agreement Covering any Binder; and (b) any Patent Rights claiming the foregoing Know-How in Section 1.12(a) Covering any Binder, but in each case specifically excludes the Pieris Platform Improvement IP and the Pieris Background IP. 1.13 Biosimilar Product The term “Biosimilar Product” shall mean a product that is not produced, licensed or owned by the Roche Group and is, according to the relevant Regulatory Authority for the given country or jurisdiction, highly similar with respect to a given Collaboration Product, notwithstanding minor differences in clinically inactive components, and with no clinically meaningful differences between the Biosimilar Product and the given Collaboration Product in terms of the safety, purity and potency of the product. For countries or jurisdictions where no explicit biosimilar regulations exist, Biosimilar Product includes products which (i) have been deemed to be a Biosimilar Product by a Regulatory Authority in another country or jurisdiction or (ii) have the identical amino acid sequence.
View Source

Examples of Binder IP in a sentence

  • Further, with respect to Antibody Binder IP generated by or on behalf of Company, Company shall disclose [***] to Merck upon request via the Joint Working Group or JRCC.

  • Merck shall have (a) the sole right to file, prosecute, and maintain patent applications claiming Antibody Binder IP [***] and (b) the first right to file patent applications claiming Collaboration Candidate IP.

  • Merck shall have the first right to control such proceedings with respect to Collaboration Candidate IP, Antibody Binder IP and Other Collaboration IP, and Company shall have the right to review [***] any submission to be made [***].

  • Company shall promptly disclose to Merck in writing the conception, creation or discovery of such Collaboration Candidate IP and Antibody Binder IP to which one or more patent applications may be filed.

  • Nurix hereby assigns to Gilead, and will assign to Gilead, all of Nurix's rights, title and interests in and to any and all Gilead Target Binder IP.

  • Binder IP The term “Non-Selected-Binder IP” is defined in Section 14.2.

  • In addition, Nurix will promptly disclose to Gilead all Gilead Target Binder IP, and will perform all actions reasonably requested by G▇▇▇▇▇ to permit and assist G▇▇▇▇▇ in evidencing, perfecting, obtaining, maintaining, defending and enforcing G▇▇▇▇▇'s rights in Gilead Target Binder IP, including executing all relevant documents (including written assignments to Gilead).